Brought to you by 
superDimension grosses $27mm with Series B round
30 Jun 2005
Executive Summary
Israeli medical device company superDimension Ltd. (focuses on lung diseases) has grossed $27mm with its Series B round led by OrbiMed, which invested $12.5mm and is now the company's largest shareholder. New investors, CIBC World Markets and the strategic investments group of Pfizer, joined most of the company's existing backers, including Oxford Bioscience Partners, Pitango Venture Capital, Medica Venture Partners, and Mi3 Venture Capital.
Deal Industry
- Medical Devices
-
Medical Devices
-
Surgical Equipment & Devices
- Minimally or Less Invasive
-
Surgical Equipment & Devices
Deal Status
- Final
Deal Type
-
Financing
- Venture Financing
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
superDimension grosses $27mm with Series B round
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice